MicroRNAs from peripheral blood mononuclear cells as biomarkers for detection of preclinical fibrosarcoma by Adriane F Evangelista et al.
POSTER PRESENTATION Open Access
MicroRNAs from peripheral blood mononuclear
cells as biomarkers for detection of preclinical
fibrosarcoma
Adriane F Evangelista1, Danilo J Xavier2, Elza T Sakamoto-Hojo2, Eduardo A Donadi2, Geraldo A Passos2,
Marcia MCM Silveira1*
From São Paulo Advanced School of Comparative Oncology
Águas de São Pedro, Brazil. 30 September - 6 October 2012
Background
Blood immune cells cooperate to prevent the progres-
sion of tumors through cancer immunosurveillance.
Since activated peripheral immune cell clones trigger a
sensitive transcriptional response upon recognition of
tumors, which can be identified by transcriptional profil-
ing, we hypothesised that peripheral blood mononuclear
cells (PBMCs) could be used as reporters for cancer
detection.
Materials and methods
We used a model system in which groups of immunocom-
petent BALB-c mice were subcutaneously injected with
different numbers of tumorigenic B61 fibrosarcoma cells.
The groups of study were: (i) tumoral group with serial
injections of 102 to 106 cells; (ii) negative control group
represented by sterile nonpyrogenic saline, (iii) inflamma-
tion group by Zymozan (Sigma) and (iv) bacterial infection
group by injection of 107colony forming units [cfu] pool
from mice feces. Mouse peripheral blood was collected
three days after injection; blood samples (N=10) were
pooled according to experimental conditions. Mononuc-
lear cells were separated by centrifugation on a Ficoll-
Hypaque cushion (GE Healthcare) and RNA was extracted
using Trizol Reagent (Invitrogen). Samples were hybri-
dizated on miRNA microarrays (Agilent).
Results
We identified four microRNAs, miR-451, miR-144, miR-
486 and miR-494, which were differentially expressed
when compared to control groups, including inflammation
and bacterial infection.
Conclusions
Our results showed that PBMC microRNA expression
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